Generic drug of the therapeutic class: Dermatology
active ingredients: Betamethasone
laboratory: Msd France
30 g tube
1. Preferred indications where local corticosteroid therapy is held for the best treatment:
· Contact eczema
· atopic dermatitis
2. Indications where local corticosteroid therapy is one of the usual treatments:
· Stasis dermatitis
· Psoriasis (excluding extensive plaques)
· Non-parasitic prurigo
· Sclero-atrophic genital lichen
· Granuloma annulare
· Discoid lupus erythematosus
· Seborrheic dermatitis with the exception of the face
· Symptomatic treatment of pruritus of mycosis fungoides
3. Indication of circumstances for a short period of time:
Insect bites and parasitic prurigo after etiological treatment.
The ointment form is more particularly intended for dry or scaly lesions.
Note: Each dermatosis must be treated with a corticosteroid of the most appropriate level knowing that depending on the results, we may be led to substitute a product with a stronger or less strong activity on all or part of the lesions.
Dosage DIPROSONE 0.05% Ointment Tube of 30 g
Treatment should be limited to 1 to 2 applications per day.
An increase in the number of daily applications could aggravate the adverse effects without improving the therapeutic effects.
The treatment of large areas requires monitoring of the number of tubes used.
It is advisable to apply the product in spaced keys, then to spread it while massaging slightly until it is entirely absorbed.
Some dermatoses (psoriasis, atopic dermatitis ...) make it desirable to stop gradually. It can be obtained by reducing the frequency of applications and / or by the use of a less strong or less dosed corticosteroid.
· Hypersensitivity to the active substance or to any of the excipients.
· Primitive bacterial, viral, fungal or parasitic infections.
· Ulcerated lesions.
· Application on the eyelids (risk of glaucoma).
Diprosone side effects
Prolonged use of corticosteroids with strong activity may result in skin atrophy, telangiectasia (to be particularly feared on the face), stretch marks (at the root of the limbs in particular, and occurring more readily in adolescents), a secondary ecchymotic purpura to atrophy, skin fragility.
In the face, corticosteroids can create perioral dermatitis or aggravate rosacea (see sections Warnings and precautions for use and Contraindications ).
It can be observed a delay of healing of uninjured wounds, pressure ulcers, leg ulcers (see Contraindications section ).
Potential for systemic effects (see Warnings and Precautions for Use section ).
Acneiform or pustular eruptions, hypertrichosis, depigmentations have been reported.
Secondary infections, especially under occlusive dressing or in folds and allergic contact dermatoses have also been reported when using local corticosteroids.